CT透视引导下小肾肿瘤冷冻消融的患者辐射剂量
本研究纳入72例小肾肿瘤冷冻消融手术,评估CT透视引导下的患者辐射剂量。结果显示CT透视贡献了89.8%的SSDE剂量,总ESD未超过1 Gy。冷冻针穿刺次数增加及联合水分离/气分离技术会显著增加总ESD。
要点
- CT透视是冷冻消融术中辐射剂量的主要来源,占SSDE的89.8%。
- 总ESD最大值863 mGy,未超过1 Gy。
- 穿刺针数增加和联合水分离/气分离会提高总ESD。
局限性
- 回顾性单中心研究,样本量有限(72例)。
- 仅评估了部分剂量指标,未涉及长期辐射风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: This study aimed to evaluate patients' radiation dose in computed tomography (CT)-fluoroscopy-guided cryoablation for small renal tumors and assess the possible factors affecting it.
METHODS: In our institution, cryoablation was performed in 152 patients between 2013 and 2020. Procedures that were not for renal tumors and did not have radiation dose records and detailed information were excluded from the analysis. The size-specific dose estimates (SSDE), volume CT dose index (CTDIvol), dose-length product (DLP), and entrance skin dose (ESD) were evaluated for both spiral scan and CT-fluoroscopy. The effects of the number of cryoneedle punctures; combined use of hydro- and/or pneumodissection procedures; patients' characteristics, such as body-mass index (BMI); and the tumor-related factors, such as tumor location, were determined by the univariate and multivariate analyses.
RESULTS: In the 72 included procedures, the median SSDE was 658 mGy and the median CTDIvol was 456 mGy. The median percentage dose of CT-fluoroscopy to the total procedure dose was estimated as 89.8% (591/658 mGy) with SSDE and 41.4% (611/1,475 mGy cm) with DLP. The combined use of hydro- and/or pneumodissection and number of cryoneedle punctures were significantly associated with the total ESD, and the maximum total ESD was 863 mGy in our cases.
CONCLUSIONS: Using SSDE as an index, 89.8% of patients' radiation dose was attributed to CT-fluoroscopy, and ESD for the total procedure did not exceed 1 Gy. The increased number of cryoneedle punctures and combined use of hydro- and/or pneumodissection increased the total ESD.
引用
- Fukushima Y, Nakamura J, Seki Y, et al. Patients' radiation dose in computed tomography-fluoroscopy-guided percutaneous cryoablation for small renal tumors. Eur J Radiol. 2021. PMID: 34619620. doi:10.1016/j.ejrad.2021.109972
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。